These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26853441)

  • 1. Synthesis and Pharmacological Activity of a New Series of 1-(1H-Indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol Analogs.
    Bednarski M; Otto M; Dudek M; Kołaczkowski M; Bucki A; Siwek A; Groszek G; Maziarz E; Wilk P; Sapa J
    Arch Pharm (Weinheim); 2016 Mar; 349(3):211-23. PubMed ID: 26853441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol and its enantiomers. Part 1.
    Groszek G; Bednarski M; Dybała M; Filipek B
    Eur J Med Chem; 2009 Feb; 44(2):809-17. PubMed ID: 18599160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and adrenolytic activity of 1-(1H-indol-4-yloxy)-3-(2-(2-methoxy phenoxy)ethylamino)propan-2-ol analogs and its enantiomers. Part 2.
    Groszek G; Nowak-Król A; Wdowik T; Swierczyński D; Bednarski M; Otto M; Walczak M; Filipek B
    Eur J Med Chem; 2009 Dec; 44(12):5103-11. PubMed ID: 19647907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic activity in occlusion-reperfusion model of 1-(1H-indol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino} propan-2-ol and its enantiomers.
    Bednarski M; Otto M; Dudek M; Siwek A; Zygmunt M; Knutelska J; Nowiński L; Groszek G; Sapa J
    Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):81-7. PubMed ID: 26384857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and adrenolytic activity of new propanolamines.
    Groszek G; Bajek A; Bis A; Nowak-Król A; Bednarski M; Siwek A; Filipek B
    Molecules; 2010 May; 15(6):3887-904. PubMed ID: 20657415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective LC/ESI-MS/MS analysis and pharmacokinetic and tissue distribution study of (2RS)-1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-propan-2-ol in rats.
    Walczak M; Szymura-Oleksia J; Groszek G
    Chirality; 2012 Aug; 24(8):591-9. PubMed ID: 22714390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
    Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
    Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
    Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Zmudzki P; Pawłowski M; Zygmunt M; Filipek B
    Pharmacol Rep; 2011; 63(2):476-86. PubMed ID: 21602603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide/soluble cyclic guanylase/cyclic guanosine monophosphate pathway is involved in the cardiovascular effects of a novel α1- and β-adrenoceptor antagonist.
    Kubacka M; Mogilski S; Bednarski M; Raźny K; Sapa J; Waszkielewicz AM; Marona H; Filipek B
    Pharmacology; 2014; 94(5-6):287-95. PubMed ID: 25531925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-[(Imidazolidin-2-yl)imino]-1H-indoles as new hypotensive agents: synthesis and in vitro and in vivo biological studies.
    Kornicka A; Wasilewska A; Sączewski J; Hudson AL; Boblewski K; Lehmann A; Gzella K; Belka M; Sączewski F; Gdaniec M; Rybczyńska A; Bączek T
    Chem Biol Drug Des; 2017 Mar; 89(3):400-410. PubMed ID: 27566285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of new 1-(amino)-3-[(1,5-diphenyl-1H-1,2,4-triazol-3-yl) oxy] propan-2-ol and 1-[(1,5-diphenyl- 1H- 1,2,4-triazol-3-yl) oxy]-3-(4-arylpiperazin-1-yl) propan-2-ol derivatives with an expected beta-adrenolytic activity.
    Kossakowski J; Struga M; Kozioł AE
    Acta Pol Pharm; 2006; 63(4):255-9. PubMed ID: 17203860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
    Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
    J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and preliminary biological evaluation of novel N-substituted 1-amino-3-[1-methyl(phenyl)-1H-indazol-4-yloxy]-propan-2-ols interesting as potential antiarrhythmic, local anaesthetic and analgesic agents.
    Mosti L; Menozzi G; Fossa P; Filippelli W; Gessi S; Rinaldi B; Falcone G
    Arzneimittelforschung; 2000 Nov; 50(11):963-72. PubMed ID: 11148862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
    Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK
    J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
    Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.